European Markets for Spinal Implants and VCF

Publisher Name :
Date: 1-Feb-2013
No. of pages: 420

A complete overview of every segment within this report. This summary includes an abridged competitive analysis, partial numerical data, CAGRS, and qualitative synopses.The European spinal implant market is expected to exceed €1 billion by 2018. Growth in the interbody fusion device segment will continue to be the largest contributor to the rising spinal implant market. The European market for spinal implants includes traditional thoracolumbar (TL) fixation, cervical fixation, interbody fusion, dynamic stabilization, artificial discs and vertebral compression fractures (VCF). Despite many current challenges, positive growth is expected in all segments of the market, as the patient demographics in Europe maintain a steady demand for such procedures. However, the interbody fusion device market will lead the other markets in terms of growth, throughout the forecast period. The market for minimally invasive surgery (MIS) spinal implants is also a rapidly growing market in Europe. This segment, while included in the report, is not discussed in detail.

Scope:

This report pertains to a forecast period of 10 years (2008 – 2018) for Austria, Belgium, Denmark, Finland, France,Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.

Report Contents:

  • Competitor Analysis
  • Identified Strategic Opportunities
  • Market Overview by Segment & Country
  • Trend Analysis by Segment & Country
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring

Main Segments Included:

  • Spinal Implant Market
  • The Human Spine
  • Thoracolumbar Fixation Market
  • Cervical Fixation Market
  • Interbody Fusion Market
  • European Spinal Fusion Market: Competitive Analysis
  • Dynamic Stabilization Market
  • Artificial Disc Market
  • Spinal Vcf Market
  • Minimally Invasive Spinal Implant Devices

Subsegments Included:

  • Spinal Fusion
  • Traditional Interbody Fusion
  • Minimally Invasive Interbody Fusion
  • Artificial Discs
  • Dynamic Stabilization
  • Vertebral Compression Fracture (VCF)
  • Degenerative Disc Disease
  • Spinal Deformities
  • Kyphosis and Lordosis
  • Vertebral Compression Fractures
  • Decompression
  • Microdecompression
  • Laminectomy
  • Discectomy
  • Spinal Fusion
  • Corpectomy
  • Spinal Arthroplasty
  • Degenerative Thoracolumbar Fixation
  • Thoracolumbar Deformity Correction
  • Trauma/Tumor Thoracolumbar Fixation
  • Anterior Cervical Fixation
  • Posterior Cervical Fixation

Companies Included:

  • Medtronic
  • Medicrea
  • Spine Vision
  • Alphatec Spine
  • Biomet
  • Paradigm Spine
  • Dfine
  • LDR
  • Ulrich Medical
  • Optimed
  • Spine Art
  • MBA Incorporado
  • CareFusion Synthes
  • DePuy
  • Zimmer
  • Stryker
  • Aesculap
  • Spinal Kinetics
  • NeuroTherm
  • Cook Medical
  • Somatex

Others Include:
Acuña Fombona, Anatomica, AxioMed, Biospine Implants, coLigne, Cousin Biotech, Covision Medical, Creaspine, Globus Medical, Interventional Spine, Joimax, Kiscomedica, Neuro France Implants, NuVasive, Orthofix, OSD Development, Peter Brehm, Pioneed Surgical, Privelop, Ranier, Sintea Biotech, Somatex Medical, Somepic Technologies, Spinal Motion, SpineVision, Surgicraft, Vertiflex, Vexim, etc.

Reasons to Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.

European Markets for Spinal Implants and VCF

Table Of Contents

Table Of Contents  I
List Of Figures  VIII
List Of Charts  XVII

Executive Summary  1
1.1 European Market For Spinal Implants 1
1.2 Trend Analysis By Segment   2
1.3 Thoracolumbar Fixation Market 3
1.4 Cervical Fixation Market 4
1.5 Interbody Device Market 5
1.6 Dynamic Stabilization Market 6
1.7 Artificial Disc Market  7
1.8 Vertebral Compression Fracture (Vcf)Market 8
1.9 Competitive Analysis   9

Research Methodology  10
2.1 Research Scope  10
2.2 Idata’s 9-Step Methodology  10
Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems And Perform Secondary Research 13
Step 3: Preparation For Interviews & Questionnaire Design     14
Step 4: Performing Primary Research  15
Step 5: Research Analysis: Establishing Baseline Estimates     17
Step 6: Market Forecast And Analysis 18
Step 7: Identify Strategic Opportunities 20
Step 8: Final Review And Market Release 21
Step 9: Customer Feedback And Market Monitoring 22

European Spinal Implant Market 23
3.1 Introduction   23
3.1.1.1 Spinal Fusion 23
3.1.1.2 Traditional Interbody Fusion  24
3.1.1.3 Minimally Invasive Interbody Fusion 25
3.1.1.4 Artificial Discs 27
3.1.1.5 Dynamic Stabilization  27
3.1.1.6 Vertebral Compression Fracture (Vcf) 28
3.2 Currency Exchange Rate 29
3.3 Market Overview   30
3.4 Market By Segment  32
3.5 Market By Country   36
3.6 Trend Analysis  40
3.7 Market Drivers & Limiters   45
3.7.1 Market Drivers  45
3.7.2 Market Limiters  46
3.8 Competitive Analysis  49
3.8.1 Leading Competitors   49
3.9 Mergers And Acquisitions  55

The Human Spine    60
4.1 Basic Anatomy 60
4.2 Spinal Pathology & Disorders 63
4.2.1 Degenerative Disc Disease 63
4.2.1.1 Disc Herniation    63
4.2.1.2 Stenosis   64
4.2.1.3 Spondylolisthesis    64
4.2.1.4 Arthritis    64
4.2.2 Spinal Deformities   65
4.2.2.1 Scoliosis   65
4.2.2.2 Kyphosis And Lordosis  65
4.2.3 Trauma And Tumor  65
4.2.4 Vertebral Compression Fractures 65
4.2.4.1 Osteoporosis  65
4.2.4.2 Vertebral Compression Fractures 66
4.3 Spinal Disorder Treatments 67
4.3.1 Decompression  67
4.3.1.1 Microdecompression  67
4.3.1.2 Laminectomy  67
4.3.2 Discectomy    67
4.3.3 Spinal Fusion  68
4.3.4 Corpectomy   68
4.3.5 Spinal Arthroplasty  68

Country Profiles  69
5.1 Introduction   69
5.1.1 Population    69
5.1.2 Gdp Per Capita 69
5.1.3 Fpm And Nfpm Penetration Rates 69
5.1.4 Price Index    70
5.2 Germany    71
5.3 France  72
5.4 U.K.    73
5.5 Italy   74
5.6 Spain    75
5.7 Benelux (Belgium, Netherlands And Luxembourg)     76
5.8 Scandinavia (Denmark, Finland, Norway And Sweden) 77
5.9 Austria     78
5.10 Switzerland   79
5.11 Portugal    80

Thoracolumbar Fixation Market 81
6.1 Introduction   81
6.1.1.1 Degenerative Thoracolumbar Fixation 82
6.1.1.2 Thoracolumbar Deformity Correction 82
6.1.1.3 Trauma/Tumor Thoracolumbar Fixation 83
6.2 Market Overview   84
6.3 Market Analysis And Forecast 88
6.3.1 Germany    88
6.3.2 France     91
6.3.3 U.K.    94
6.3.4 Italy   97
6.3.5 Spain  100
6.3.6 Benelux (Belgium, Netherlands And Luxembourg) 103
6.3.6.1 Belgium   104
6.3.6.2 Netherlands  105
6.3.7 Scandinavia (Denmark, Finland, Norway, And Sweden)     115
6.3.8 Austria     128
6.3.9 Switzerland   131
6.3.10 Portugal   134
6.4 Market Drivers And Limiters 138
6.4.1 Market Drivers  138
6.4.2 Market Limiters    139

Cervical Fixation Market 142
7.1 Introduction   142
7.1.1.1 Anterior Cervical Fixation  143
7.1.1.2 Posterior Cervical Fixation 144
7.2 Market Overview  145
7.3 Market Analysis And Forecast 149
7.3.1 Germany    149
7.3.2 France     152
7.3.3 U.K.   155
7.3.4 Italy  158
7.3.5 Spain  161
7.3.6 Benelux (Belgium, Netherlands And Luxembourg) 164
7.3.6.1 Belgium   165
7.3.6.2 Netherlands  165
7.3.7 Scandinavia (Denmark, Finland, Norway And Sweden)     175
7.3.8 Austria     188
7.3.9 Switzerland   191
7.3.10 Portugal   194
7.4 Market Drivers And Limiters 197
7.4.1 Market Drivers  197
7.4.2 Market Limiters    198

Interbody Fusion Market 200
8.1 Introduction   200
8.1.1 Material Type  202
8.1.1.1 Metal    202
8.1.1.2 Peek   202
8.1.1.3 Machined Bone   202
8.2 Market Overview  203
8.3 Market Analysis And Forecast 208
8.3.1 Germany    208
8.3.2 France     211
8.3.3 U.K.   214
8.3.4 Italy  217
8.3.5 Spain  221
8.3.6 Benelux (Belgium, Netherlands And Luxembourg) 224
8.3.6.1 Belgium   224
8.3.6.2 The Netherlands   225
8.3.7 Scandinavia (Denmark, Finland, Norway And Sweden)     235
8.3.8 Austria     248
8.3.9 Switzerland   251
8.3.10 Portugal   254
8.4 Market Drivers And Limiters 257
8.4.1 Market Drivers  257
8.4.2 Market Limiters    258

European Spinal Fusion Market: Competitive Analysis   261
9.1 Introduction   261
9.2 Competitive Analysis  261
9.2.1 Total European Markets 261
9.2.2 Germany    268
9.2.3 France     268
9.2.4 U.K.   269
9.2.5 Italy  269
9.2.6 Spain  269
9.2.7 Benelux    270
9.2.8 Scandinavia   271
9.2.9 Austria     272
9.2.10 Switzerland   272
9.2.11 Portugal   272

Dynamic Stabilization Market 273
10.1 Introduction  273
10.2 Market Overview  274
10.3 Market Analysis And Forecast 277
10.3.1 Dynamic Stabilization Market By Country 277
10.3.2 Posterior Dynamic Stabilization Market By Country     284
10.3.3 Interspinous Dynamic Stabilization Market By Country     291
10.4 Market Drivers And Limiters 298
10.4.1 Market Drivers    298
10.4.2 Market Limiters    299
10.5 Competitive Analysis  301

Artificial Disc Market   305
11.1 Introduction  305
11.2 Market Overview  306
11.3 Market Analysis And Forecast 309
11.3.1 Artificial Disc Market By Country 309
11.3.2 Lumbar Artificial Disc Market By Country 316
11.3.3 Cervical Artificial Disc Market By Country 324
11.4 Market Drivers And Limiters 331
11.4.1 Market Drivers    331
11.4.2 Market Limiters    332
11.5 Competitive Analysis  335

Spinal Vcf Market  338
12.1 Introduction  338
12.1.1 Percutaneous Vertebroplasty  339
12.1.2 Percutaneous Vertebral Augmentation Including Kyphoplasty     340
12.1.3 Effects Of New England Journal Of Medicine Publication 341
12.2 Market Overview  342
12.3 Market Analysis And Forecast 345
12.3.1 Vcf Market By Country 345
12.3.2 Pva Market By Country 352
12.3.3 Vertebroplasty Market By Country 360
12.4 Market Drivers And Limiters 367
12.4.1 Market Drivers    367
12.4.2 Market Limiters    368
12.5 Competitive Analysis  371
12.5.1 Leading Companies And Products 371
12.5.2 Emerging Companies And Products 375

Appendix: Minimally Invasive Spinal Implant Devices    377
13.1 Introduction  377
13.2 Mis Interbody Fusion 377
13.2.1 Approach Types   378
13.2.1.1 Minimally Invasive Plif (Miplif) 378
13.2.1.2 Minimally Invasive Tlif (Mitlif) 378
13.2.1.3 Lateral Lumbar Interbody Fusion (Llif) 379
13.3 Mis Pedicle Screw Fixation  380
13.3.1 System Types  381
13.4 Market Analysis And Forecast 381

Abbreviations  383

  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Global Epilepsy Drug Market Continues to Grow Steadily
    The global epilepsy drug market has grown steadily in recent years with increased sales of anti-epileptic drugs which are targeted at reducing seizures. Epilepsy is a condition which affects the brain and is characterized with repeated seizures in the patient. Treatment for epilepsy usually involves the use of medicines known as anti-epileptic drugs which prevents [...]
  • Global Meat and Poultry Product Market to Witness Steady Growth
    As global demand for meat and poultry products continues to rise, the market for meat and poultry is also expected to grow steadily. The market for meat and poultry products is driven by rise in disposable income, growing awareness among consumers about the importance of adding protein to their diet, and change in eating habits. [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Bacterial Pneumonia Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 146
    GlobalData's clinical trial report, "Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, ......
  • Aspergillosis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 125
    GlobalData's clinical trial report, "Aspergillosis Global Clinical Trials Review, H2, 2014" provides data on the Aspergillosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aspergillosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the ......
  • Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 79
    GlobalData's clinical trial report, "Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcal Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, tr......
  • Cerebral (Fatal) Malaria Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 64
    GlobalData's clinical trial report, "Cerebral (Fatal) Malaria Global Clinical Trials Review, H2, 2014" provides data on the Cerebral (Fatal) Malaria clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral (Fatal) Malaria. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase,......
  • African Trypanosomiasis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 48
    GlobalData's clinical trial report, "African Trypanosomiasis Global Clinical Trials Review, H2, 2014" provides data on the African Trypanosomiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on African Trypanosomiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, tr......
  • Cryptosporidiosis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 58
    GlobalData's clinical trial report, "Cryptosporidiosis Global Clinical Trials Review, H2, 2014" provides data on the Cryptosporidiosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptosporidiosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, promin......
  • Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 70
    GlobalData's clinical trial report, "Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014" provides data on the Cytomegalovirus (CMV) Retinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cytomegalovirus (CMV) Retinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical t......
  • Dermatophytosis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 86
    GlobalData's clinical trial report, "Dermatophytosis Global Clinical Trials Review, H2, 2014" provides data on the Dermatophytosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dermatophytosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence o......
  • Bacterial Sepsis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 65
    GlobalData's clinical trial report, "Bacterial Sepsis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Sepsis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Sepsis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominenc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs